Background/Aims: Exposure to HBV leads to a distinct clinical course which is partially pertained to host genetic variability. We aimed to study polymorphisms of type I interferon receptor 1 (IFNAR1) promoter and their potential effects on chronic HBV infection. Methods: Polymorphisms of IFNAR1 promoter were identified in 320 chronic hepatitis B patients, 148 spontaneously recovered individuals, 148 healthy Chinese donors and 114 Caucasians. Their functional capability in driving reporter gene expression was analyzed. Results: Four polymorphic alleles were identified at loci -568, -408, -77 and -3. Association analysis revealed that carriers of alleles -568G, -408C and their related haplotype I were less susceptible to chronic HBV infection...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
International audienceObjectivesThe interferon (IFN) is known to bridge innate and adaptive immune r...
Background: Based on differences in individual immune responses to the hepatitis B virus (HBV), betw...
The type I interferon (IFN-α/β) receptor 1 (IFNAR1) mediates the potent antiviral and immuno-regulat...
Background/Aims: We previously demonstrated that two linked single nucleotide polymorphisms (SNPs) a...
The antiviral cascade triggered by interferon-γ (IFN-γ) represents a vital event for eradicating hep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactiv...
Background and aims: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNA...
The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactiv...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
International audienceObjectivesThe interferon (IFN) is known to bridge innate and adaptive immune r...
Background: Based on differences in individual immune responses to the hepatitis B virus (HBV), betw...
The type I interferon (IFN-α/β) receptor 1 (IFNAR1) mediates the potent antiviral and immuno-regulat...
Background/Aims: We previously demonstrated that two linked single nucleotide polymorphisms (SNPs) a...
The antiviral cascade triggered by interferon-γ (IFN-γ) represents a vital event for eradicating hep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
Implication for health policy/practice/research/medical education: Chronic hepatitis B infection dep...
The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactiv...
Background and aims: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNA...
The outcome of HBeAg-negative chronic hepatitis B virus (HBV) patients who may remain in the inactiv...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
[[abstract]]Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis ...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Background and aims<p>Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFN...
Interferon alfa (IFN-alpha) therapy remains a mainstay of treatment in active hepatitis B. However, ...
International audienceObjectivesThe interferon (IFN) is known to bridge innate and adaptive immune r...
Background: Based on differences in individual immune responses to the hepatitis B virus (HBV), betw...